Humanwell PuraCap Pharmaceutical (Wuhan)

Humanwell PuraCap Pharmaceutical (Wuhan) is a high-tech joint venture between Humanwell Healthcare Group and PuraCap Pharmaceutical LLC. The company specializes in the development and manufacturing of high-quality softgel capsules and solid oral dosage forms for the global market, with a strong focus on the US and Chinese markets. Their facility in Wuhan is designed to meet US FDA and Chinese GMP standards, providing both proprietary products and contract manufacturing services. The company's portfolio primarily includes over-the-counter (OTC) and prescription medications across various therapeutic areas such as pain relief and respiratory health.